![PRD_000252 PRD_000252](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000252.svg) | PRD_000252 | Name: | Ac-Tyr-Val-Ala-Asp-Aldehyde | Formula: | C23 H32 N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000257 PRD_000257](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000257.svg) | PRD_000257 | Name: | N-{(2S)-2-[(N-acetyl-4-carbamimidoyl-L-phenylalanyl)amino]-2-cyclohexylacetyl}-3-(1-methylpyridinium-3-yl)-
L-alanyl-D-leucyl-L-prolinamide | Formula: | C40 H58 N9 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000259 PRD_000259](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000259.svg) | PRD_000259 | Name: | N-acetyl-L-tryptophyl-L-alpha-glutamyl-N-[(1R)-2-carboxy-1-formylethyl]-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide | Formula: | C28 H36 N7 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000265 PRD_000265](https://data.pdbj.org/pdbjplus/data/cc/svg/0EO.svg) | PRD_000265 | Name: | (2S)-2-[[(3S,4S)-5-cyclohexyl-4-[[(4S,5S)-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxidanyl-6-phenyl-hexanoyl]amino]
-3-oxidanyl-pentanoyl]amino]-4-methyl-pentanoic acid | Formula: | C34 H55 N3 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000266 PRD_000266](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000266.svg) | PRD_000266 | Formula: | C52 H81 N11 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000267 PRD_000267](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000267.svg) | PRD_000267 | Name: | H-261 Oligopeptide | Formula: | C55 H84 N13 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000268 PRD_000268](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000268.svg) | PRD_000268 | Name: | L-364,099 | Formula: | C54 H77 N11 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000270 PRD_000270](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000270.svg) | PRD_000270 | Name: | 4-biphenylacetyl-CYS-(D)ARG-TYR-N-(2-phenylethyl) amide | Formula: | C40 H49 N7 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000272 PRD_000272](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000272.svg) | PRD_000272 | Name: | CBZ-DEHYDRO-LEU-VAL-ARG-TYR | Formula: | C34 H50 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000275 PRD_000275](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000275.svg) | PRD_000275 | Name: | Ac-DADE-F(2)Pmp-L-NH(2) | Formula: | C32 H46 F2 N7 O15 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000276 PRD_000276](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000276.svg) | PRD_000276 | Name: | Thrombostatin FM inhibitor [rOicPaF(p-Me)] | Formula: | C33 H52 N9 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000280 PRD_000280](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000280.svg) | PRD_000280 | Name: | HIV ENTRY INHIBITOR PIE1 | Formula: | C80 H118 N22 O22 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000281 PRD_000281](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000281.svg) | PRD_000281 | Name: | HIV ENTRY INHIBITOR PIE7 | Formula: | C81 H110 N20 O22 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000282 PRD_000282](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000282.svg) | PRD_000282 | Name: | N-acetyl-L-alpha-aspartyl-L-asparaginyl-N-[(1R)-2-carboxy-1-formylethyl]-L-leucinamide | Formula: | C20 H33 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000284 PRD_000284](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000284.svg) | PRD_000284 | Name: | AC-DQMD-CHO | Formula: | C20 H33 N5 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000285 PRD_000285](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000285.svg) | PRD_000285 | Name: | L-tryptophyl-L-tyrosyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-threoninamide | Formula: | C31 H44 Cl N8 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000289 PRD_000289](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000289.svg) | PRD_000289 | Name: | BETA-SECRETASE INHIBITOR OM00-3 | Formula: | C44 H69 N7 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000290 PRD_000290](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000290.svg) | PRD_000290 | Name: | BETA-SECRETASE INHIBITOR OM99-2 | Formula: | C41 H64 N8 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000293 PRD_000293](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000293.svg) | PRD_000293 | Name: | INHIBITOR AC-ESMD-CHO | Formula: | C19 H32 N4 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000298 PRD_000298](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000298.svg) | PRD_000298 | Name: | N-[(2R)-3-phenyl-2-{[L-prolyl-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}propyl]-L-phenylalanyl-L-valyltyrosine | Formula: | C58 H72 N12 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000300 PRD_000300](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000300.svg) | PRD_000300 | Name: | N-acetyl-L-isoleucyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-prolinamide | Formula: | C22 H36 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000301 PRD_000301](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000301.svg) | PRD_000301 | Name: | N-(2-oxoethyl)-L-isoleucyl-L-alpha-glutamyl-N-[(1R)-2-carboxy-1-formylethyl]-L-threoninamide | Formula: | C21 H36 N4 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000306 PRD_000306](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000306.svg) | PRD_000306 | Name: | KPFS-(CH2-NH)-LQF peptidomimetic inhibitor of PfPM1 | Formula: | C49 H77 N10 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000309 PRD_000309](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000309.svg) | PRD_000309 | Name: | L-leucyl-N-(2-oxopropyl)-L-phenylalaninamide | Formula: | C26 H31 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000313 PRD_000313](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000313.svg) | PRD_000313 | Name: | MeOSuc-Ala-Ala-Pro-boroIle | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|